Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma

Clinical trial NCT00401024 · COMPLETED

Trial details

NCT number: NCT00401024
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2006-10-12
Primary completion: 2008-02-04
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.